Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) Gross Margin %: 91.36% (As of Mar. 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Singapore Institute Of Advanced Medicine Holdings Gross Margin %?

Singapore Institute Of Advanced Medicine Holdings SGX:9G2 +3.45% Gross Margin % is 91.36% as of Mar. 2026, which is 0% below its 10-year median of 91.78. The stock has 2 warning signs investors should review. Among 629 Healthcare Providers & Services companies, Singapore Institute Of Advanced Medicine Holdings ranks better than 95.23% on this metric.

Gross Margin % is calculated as gross profit divided by its revenue. Singapore Institute Of Advanced Medicine Holdings's Gross Profit for the three months ended in Mar. 2026 was S$3.48 Mil. Singapore Institute Of Advanced Medicine Holdings's Revenue for the three months ended in Mar. 2026 was S$3.81 Mil. Therefore, Singapore Institute Of Advanced Medicine Holdings's Gross Margin % for the quarter that ended in Mar. 2026 was 91.36%.


The historical rank and industry rank for Singapore Institute Of Advanced Medicine Holdings's Gross Margin % or its related term are showing as below:

SGX:9G2' s Gross Margin % Range Over the Past 10 Years
Min: 91.12   Med: 91.78   Max: 92.28
Current: 91.98


During the past 5 years, the highest Gross Margin % of Singapore Institute Of Advanced Medicine Holdings was 92.28%. The lowest was 91.12%. And the median was 91.78%.

SGX:9G2's Gross Margin % is ranked better than
95.23% of 629 companies
in the Healthcare Providers & Services industry
Industry Median: 40.25 vs SGX:9G2: 91.98

Singapore Institute Of Advanced Medicine Holdings had a gross margin of 91.36% for the quarter that ended in Mar. 2026 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Singapore Institute Of Advanced Medicine Holdings was 0.00% per year.


Singapore Institute Of Advanced Medicine Holdings  (SGX:9G2) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Singapore Institute Of Advanced Medicine Holdings had a gross margin of 91.36% for the quarter that ended in Mar. 2026 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Singapore Institute Of Advanced Medicine Holdings Gross Margin % Related Terms


Singapore Institute Of Advanced Medicine Holdings Gross Margin % Historical Data

* Premium members only.

The historical data trend for Singapore Institute Of Advanced Medicine Holdings's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Singapore Institute Of Advanced Medicine Holdings Gross Margin % Chart

Singapore Institute Of Advanced Medicine Holdings Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Gross Margin %
91.12 91.23 92.28 92.27 91.78

Singapore Institute Of Advanced Medicine Holdings Quarterly Data
Jun21 Jun22 Jun23 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
Gross Margin % Get a 7-Day Free Trial Premium Member Only 0.00 91.39 92.62 0.00 91.36

SGX:9G2 vs HCA, THC, DVA: Gross Margin % Comparison

For the Medical Care Facilities subindustry, Singapore Institute Of Advanced Medicine Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Singapore Institute Of Advanced Medicine Holdings Gross Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Singapore Institute Of Advanced Medicine Holdings's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Singapore Institute Of Advanced Medicine Holdings's Gross Margin % falls into.



Singapore Institute Of Advanced Medicine Holdings Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Singapore Institute Of Advanced Medicine Holdings's Gross Margin for the fiscal year that ended in Jun. 2025 is calculated as

Gross Margin % (A: Jun. 2025 )=Gross Profit (A: Jun. 2025 ) / Revenue (A: Jun. 2025 )
=14.4 / 15.709
=(Revenue - Cost of Goods Sold) / Revenue
=(15.709 - 1.292) / 15.709
=91.78 %

Singapore Institute Of Advanced Medicine Holdings's Gross Margin for the quarter that ended in Mar. 2026 is calculated as


Gross Margin % (Q: Mar. 2026 )=Gross Profit (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=3.5 / 3.806
=(Revenue - Cost of Goods Sold) / Revenue
=(3.806 - 0.329) / 3.806
=91.36 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Margin % →
What does a Gross Margin % of 91.36% mean?
Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) has a Gross Margin % of 91.36% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Singapore Institute Of Advanced Medicine Holdings and its competitors. This is near median its historical median of 91.78. Over the past decade, Singapore Institute Of Advanced Medicine Holdings' Gross Margin % has ranged from 91.12 to 92.28. According to the industry distribution chart, Singapore Institute Of Advanced Medicine Holdings ranks #30 out of 629 companies in the Healthcare Providers & Services industry, placing it in the top 4.8%.
Is Singapore Institute Of Advanced Medicine Holdings' Gross Margin % too high?
Singapore Institute Of Advanced Medicine Holdings' current Gross Margin % of 91.36% is near median its 10-year median of 91.78. Over the past 10 years, this metric has ranged from a low of 91.12 to a high of 92.28. The Healthcare Providers & Services industry median Gross Margin % is 40.25. Singapore Institute Of Advanced Medicine Holdings' value of 91.36% is 127% above this industry median. Based on the distribution chart, Singapore Institute Of Advanced Medicine Holdings ranks #30 out of 629 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers.
How does Singapore Institute Of Advanced Medicine Holdings' Gross Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Singapore Institute Of Advanced Medicine Holdings ranks #30 out of 629 companies for Gross Margin %. This places Singapore Institute Of Advanced Medicine Holdings in the top 5% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 40.25. Singapore Institute Of Advanced Medicine Holdings' value of 91.36% is 127% above this benchmark. Historically, Singapore Institute Of Advanced Medicine Holdings' own Gross Margin % has ranged from 91.12 to 92.28 over the past decade. While the company's 10-year median is 91.78 vs. the industry median of 40.25, Singapore Institute Of Advanced Medicine Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.25, based on 629 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Singapore Institute Of Advanced Medicine Holdings's current Gross Margin % of 91.36% is 127% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Singapore Institute Of Advanced Medicine Holdings and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Singapore Institute Of Advanced Medicine Holdings's current Gross Margin % is 91.36%, which is near median its own 10-year median of 91.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Singapore Institute Of Advanced Medicine Holdings stock overvalued right now?
Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) has a current Gross Margin % of 91.36%. The current Gross Margin % is 91.36%, which is near median its 10-year median of 91.78 and 127% above the Healthcare Providers & Services industry median of 40.25. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Singapore Institute Of Advanced Medicine Holdings (SGX:9G2), the current Gross Margin % is 91.36% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Singapore Institute Of Advanced Medicine Holdings Business Description

Address 1 Biopolis Drive, No. 02-01 Amnios, Singapore, SGP, 138622
Singapore Institute of Advanced Medicine Holdings Ltd is a Singapore-based healthcare service provider comprising a medical center, diagnostic imaging facility, nuclear medicine clinic, and radiation oncology service providing proton and X-ray radiotherapy. Its operating segments are: Medical Diagnostics and Treatments, Radiation Therapy and Medical Oncology Services, and Investment Holding. Medical Diagnostics and Treatments include: cancer-related diagnostics and theranostics treatments, general diagnostics and health screening, and aesthetic services. Radiation Therapy encompasses proton beam therapy, photon radiation therapy, and Medical oncology. The majority of the company's revenue comes from the Medical Diagnostics and Treatments segment.